Deprescribing, an integral component of a continuum of good prescribing practices, is the
process of medication withdrawal or dose reduction to correct or prevent medication-related …

BACKGROUND/OBJECTIVES Guideline‐based management of cardiovascular disease
often involves prescribing multiple medications, which contributes to polypharmacy and risk …

Polypharmacy is common in older adults and associated with inappropriate medication use,
adverse drug events, medication nonadherence, higher costs, and increased mortality …

Inappropriate polypharmacy, especially in older people, imposes a substantial burden of
adverse drug events, ill health, disability, hospitalization, and even death. The single most …

Polypharmacy is a major challenge in healthcare for older people, and is associated with
increased risks of adverse outcomes, such as delirium, falls, frailty, cognitive impairment and …

Older people are prescribed a disproportionate number of medications. Polypharmacy leads
to reduced compliance, increases the risk of adverse drug effects and may lead to poor …

Aims Deprescribing is a suggested intervention to reverse the potential iatrogenic harms of
inappropriate polypharmacy. The review aimed to determine whether or not deprescribing is …

Deprescribing has gained interest recently, driven by an ageing population seeing an
increasing number living with multiple long-term conditions. This, coupled with disease …

Introduction Benefits and risks of preventive medication change over time for ageing patients
and deprescribing of medication may be needed. Deprescribing of cardiovascular and …

Older people with chronic disease have great potential to benefit from their medications but
are also at high risk of harm from their medications. The use of medications is particularly …